Dynavax (DVAX) Resumes Trading, Shares Down 60%+

Go back to Dynavax (DVAX) Resumes Trading, Shares Down 60%+

Dynavax (DVAX) to Resume Trading at 4:30PM ET

November 15, 2012 4:10 PM EST

Dynavax Technologies Corporation (NASDAQ: DVAX) is scheduled to resume trading at 4:30PM ET after an FDA panel voted against Heplisav for Heb B... More

Dynavax (DVAX) Fails to Win FDA Panel Backing on Heplisav for Hep B

November 15, 2012 1:52 PM EST

FDA advisors vote 8-5 that Dynavax Technologies Corporation (NASDAQ: DVAX) Heplisav vaccine unsafe as Hep B treatment. The panel said the vaccine hasn't shown enough safety.

Shares of Dynavax are currently halted.... More

Dynavax Technologies (DVAX) halted ahead of FDA adcom

November 15, 2012 7:01 AM EST

Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom... More